Antisense Oligonucleotides (ASOs) Drugs
Market
Antisense Oligonucleotides (ASOs) Drugs Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Antisense Oligonucleotides (ASOs) Drugs Market Size and Growth
The Antisense Oligonucleotides (ASOs) drugs market is experiencing significant growth, driven by advancements in genetic therapies and increasing prevalence of genetic disorders. The market size is projected to reach approximately $2 billion by 2025, fueled by expanding clinical applications and a robust pipeline of ASO candidates across various therapeutic areas.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Lonis Pharmaceuticals
◍ Novartis
◍ Sanofi
◍ GSK
◍ Sarepta
◍ Kastle
◍ Biogen
The Antisense Oligonucleotides (ASOs) market features companies like Lonis Pharmaceuticals, Novartis, Sanofi, GSK, Sarepta, Kastle, and Biogen, focusing on innovative therapies for genetic disorders. These firms drive growth through research, collaboration, and commercialization of ASOs, with Sarepta generating approximately $1 billion in sales revenue from its ASO products.
Request Sample Report
Market Segmentation
By Application
Request Sample Report
By Product
Cleave and Degrade
Hospital
Clinic
Market Growth
Request Sample Report
$ X Billion USD
